Arcede Pharma is a pharmaceutical company. The company conducts research and development in the field of chronic obstructive pulmonary disease, also abbreviated as COPD, and severe asthma. The company's product portfolio includes medicines intended for the treatment and relief of the above ailments. The largest activity is found within the Nordic market. The company was created via a spin-off of Respiratorius in 2022 and today has its headquarters in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
0
%
0,00%
Latest
0.08
High
0.09
Low
0.076
Volume
108 050
Turnover (SEK)
8 942
Time (Latest trade)

Board

CEO

  • Mia Lundblad

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 11,24 11,24 2023-06-28
Avanza Pension 5,92 5,92 2023-06-28
Valcuria Holding AB 3,86 3,86 2023-06-28
Ben Hayes 2,34 2,34 2023-06-28
Hans Harvig 1,72 1,72 2023-06-28
Hans Jönsson 1,71 1,71 2023-06-28
Linnart Shabo 1,70 1,70 2023-06-28
Nordnet Pensionsförsäkring 1,58 1,58 2023-06-28
Sven Niklas Anders Axelsson 1,17 1,17 2023-06-28
Andreas Bylin 1,14 1,14 2023-06-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-11-10 Delårsrapport 2023-Q3

  • 2024-02-12 Bokslutskommuniké 2023